133 related articles for article (PubMed ID: 27658391)
1. Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL.
Fransecky L; Neumann M; Heesch S; Schlee C; Ortiz-Tanchez J; Heller S; Mossner M; Schwartz S; Mochmann LH; Isaakidis K; Bastian L; Kees UR; Herold T; Spiekermann K; Gökbuget N; Baldus CD
J Hematol Oncol; 2016 Sep; 9(1):95. PubMed ID: 27658391
[TBL] [Abstract][Full Text] [Related]
2. FLT3 mutations in early T-cell precursor ALL characterize a stem cell like leukemia and imply the clinical use of tyrosine kinase inhibitors.
Neumann M; Coskun E; Fransecky L; Mochmann LH; Bartram I; Sartangi NF; Heesch S; Gökbuget N; Schwartz S; Brandts C; Schlee C; Haas R; Dührsen U; Griesshammer M; Döhner H; Ehninger G; Burmeister T; Blau O; Thiel E; Hoelzer D; Hofmann WK; Baldus CD
PLoS One; 2013; 8(1):e53190. PubMed ID: 23359050
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA profiling reveals aberrant microRNA expression in adult ETP-ALL and functional studies implicate a role for miR-222 in acute leukemia.
Coskun E; Neumann M; Schlee C; Liebertz F; Heesch S; Goekbuget N; Hoelzer D; Baldus CD
Leuk Res; 2013 Jun; 37(6):647-56. PubMed ID: 23522449
[TBL] [Abstract][Full Text] [Related]
4. Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
Bond J; Graux C; Lhermitte L; Lara D; Cluzeau T; Leguay T; Cieslak A; Trinquand A; Pastoret C; Belhocine M; Spicuglia S; Lheritier V; Leprêtre S; Thomas X; Huguet F; Ifrah N; Dombret H; Macintyre E; Boissel N; Asnafi V
J Clin Oncol; 2017 Aug; 35(23):2683-2691. PubMed ID: 28605290
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations.
Neumann M; Heesch S; Gökbuget N; Schwartz S; Schlee C; Benlasfer O; Farhadi-Sartangi N; Thibaut J; Burmeister T; Hoelzer D; Hofmann WK; Thiel E; Baldus CD
Blood Cancer J; 2012 Jan; 2(1):e55. PubMed ID: 22829239
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.
Chopra A; Bakhshi S; Pramanik SK; Pandey RM; Singh S; Gajendra S; Gogia A; Chandramohan J; Sharma A; Kumar L; Seth R; Rai S; Kumar R
Eur J Haematol; 2014 Mar; 92(3):211-8. PubMed ID: 24329989
[TBL] [Abstract][Full Text] [Related]
7. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.
Zhang J; Ding L; Holmfeldt L; Wu G; Heatley SL; Payne-Turner D; Easton J; Chen X; Wang J; Rusch M; Lu C; Chen SC; Wei L; Collins-Underwood JR; Ma J; Roberts KG; Pounds SB; Ulyanov A; Becksfort J; Gupta P; Huether R; Kriwacki RW; Parker M; McGoldrick DJ; Zhao D; Alford D; Espy S; Bobba KC; Song G; Pei D; Cheng C; Roberts S; Barbato MI; Campana D; Coustan-Smith E; Shurtleff SA; Raimondi SC; Kleppe M; Cools J; Shimano KA; Hermiston ML; Doulatov S; Eppert K; Laurenti E; Notta F; Dick JE; Basso G; Hunger SP; Loh ML; Devidas M; Wood B; Winter S; Dunsmore KP; Fulton RS; Fulton LL; Hong X; Harris CC; Dooling DJ; Ochoa K; Johnson KJ; Obenauer JC; Evans WE; Pui CH; Naeve CW; Ley TJ; Mardis ER; Wilson RK; Downing JR; Mullighan CG
Nature; 2012 Jan; 481(7380):157-63. PubMed ID: 22237106
[TBL] [Abstract][Full Text] [Related]
8. Early T-cell precursor acute lymphoblastic leukemia with
Tran T; Krause J
Proc (Bayl Univ Med Cent); 2018 Oct; 31(4):511-513. PubMed ID: 30948995
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15.
Inukai T; Kiyokawa N; Campana D; Coustan-Smith E; Kikuchi A; Kobayashi M; Takahashi H; Koh K; Manabe A; Kumagai M; Ikuta K; Hayashi Y; Tsuchida M; Sugita K; Ohara A
Br J Haematol; 2012 Feb; 156(3):358-65. PubMed ID: 22128890
[TBL] [Abstract][Full Text] [Related]
10. Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomics.
Kumar A; Drusbosky LM; Meacham A; Turcotte M; Bhargav P; Vasista S; Usmani S; Pampana A; Basu K; Tyagi A; Lala D; Rajagopalan S; Birajdar SC; Alam A; Ghosh Roy K; Abbasi T; Vali S; Sengar M; Chinnaswamy G; Shah BD; Cogle CR
Leuk Res; 2019 Mar; 78():3-11. PubMed ID: 30641417
[TBL] [Abstract][Full Text] [Related]
11. BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression?
Kawashima-Goto S; Imamura T; Tomoyasu C; Yano M; Yoshida H; Fujiki A; Tamura S; Osone S; Ishida H; Morimoto A; Kuroda H; Hosoi H
PLoS One; 2015; 10(7):e0132926. PubMed ID: 26172269
[TBL] [Abstract][Full Text] [Related]
12. Low LEF1 expression is a biomarker of early T-cell precursor, an aggressive subtype of T-cell lymphoblastic leukemia.
Wang M; Zhang C
PLoS One; 2020; 15(5):e0232520. PubMed ID: 32401815
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide DNA methylation analysis in precursor B-cells.
Almamun M; Levinson BT; Gater ST; Schnabel RD; Arthur GL; Davis JW; Taylor KH
Epigenetics; 2014 Dec; 9(12):1588-95. PubMed ID: 25484143
[TBL] [Abstract][Full Text] [Related]
14. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
15. Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.
Danis E; Yamauchi T; Echanique K; Zhang X; Haladyna JN; Riedel SS; Zhu N; Xie H; Orkin SH; Armstrong SA; Bernt KM; Neff T
Cell Rep; 2016 Mar; 14(8):1953-65. PubMed ID: 26904942
[TBL] [Abstract][Full Text] [Related]
16. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
17. Identification and targeting of treatment resistant progenitor populations in T-cell Acute Lymphoblastic Leukemia.
Tan K; Xu J; Chen C; Vincent T; Pölönen P; Hu J; Yoshimura S; Yu W; Sussman J; Chen CH; Li E; Diorio C; Shraim R; Newman H; Uppuluri L; Li A; Chen G; Bandyopadhyay S; Wu D; Ding YY; Xu J; Lim T; Hsu M; Thadi A; Ahn KJ; Wu CY; Peng J; Sun Y; Wang A; Mehta R; Frank D; Meyer L; Loh M; Raetz E; Chen Z; Wood B; Devidas M; Dunsmore K; Winter S; Chang TC; Wu G; Pounds S; Zhang N; Carroll W; Hunger S; Bernt K; Yang J; Mullighan C; Teachey D
Res Sq; 2023 Oct; ():. PubMed ID: 37961674
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of gene expression and DNA methylation patterns in childhood acute lymphoblastic leukemia].
Iijima K; Kiyokawa N
Rinsho Ketsueki; 2016 Apr; 57(4):425-9. PubMed ID: 27169445
[TBL] [Abstract][Full Text] [Related]
19. Early T-cell Precursor Acute Lymphoblastic Leukemia/Lymphoma.
Czuchlewski DR; Foucar K
Surg Pathol Clin; 2013 Dec; 6(4):661-76. PubMed ID: 26839192
[TBL] [Abstract][Full Text] [Related]
20. Complete hematologic response of early T-cell progenitor acute lymphoblastic leukemia to the γ-secretase inhibitor BMS-906024: genetic and epigenetic findings in an outlier case.
Knoechel B; Bhatt A; Pan L; Pedamallu CS; Severson E; Gutierrez A; Dorfman DM; Kuo FC; Kluk M; Kung AL; Zweidler-McKay P; Meyerson M; Blacklow SC; DeAngelo DJ; Aster JC
Cold Spring Harb Mol Case Stud; 2015 Oct; 1(1):a000539. PubMed ID: 27148573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
